Home » Topics » Regulatory » NMPA

NMPA
RSS

DC Bead approved in China for tumor embolization

Aug. 28, 2014

UC MSCs show potential in clinical study for SLE

July 30, 2014

China's regulatory authority approves phase II trials of F-351

July 3, 2014

Chinese fast track designation granted to epilepsy drug DP-VPA

June 11, 2014

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical obtains Chinese clinical trial clearance

May 22, 2014

Sihuan Pharmaceutical's application for clinical trial approval for pirotinib accepted in China

Oct. 14, 2013

Lee's Pharmaceutical submits CTA to expand the APEX study to China

Aug. 29, 2013

Lee's Pharmaceutical files to perform pivotal trial of gimatecan for ovarian cancer in China

Aug. 8, 2013

Takeda receives marketing authorization in China for Nesina

Aug. 2, 2013

Beijing Drug Administration accepts Sinovac's filing for EV71 vaccine candidate

May 31, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...